207 related articles for article (PubMed ID: 25239203)
1. The effect of short-term metformin treatment on plasma prolactin levels in bromocriptine-treated patients with hyperprolactinaemia and impaired glucose tolerance: a pilot study.
Krysiak R; Okrzesik J; Okopien B
Endocrine; 2015 May; 49(1):242-9. PubMed ID: 25239203
[TBL] [Abstract][Full Text] [Related]
2. Alternative Treatment Strategies in Women Poorly Tolerating Moderate Doses of Bromocriptine.
Krysiak R; Szkróbka W; Okopień B
Exp Clin Endocrinol Diabetes; 2017 Jun; 125(6):360-364. PubMed ID: 28073129
[No Abstract] [Full Text] [Related]
3. The effect of metformin on prolactin levels in patients with drug-induced hyperprolactinemia.
Krysiak R; Kowalcze K; Szkrobka W; Okopien B
Eur J Intern Med; 2016 May; 30():94-98. PubMed ID: 26858210
[TBL] [Abstract][Full Text] [Related]
4. Endogenous testosterone determines metformin action on prolactin levels in hyperprolactinaemic men: A pilot study.
Krysiak R; Szkróbka W; Okopień B
Basic Clin Pharmacol Toxicol; 2020 Feb; 126(2):110-115. PubMed ID: 31420971
[TBL] [Abstract][Full Text] [Related]
5. Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels.
Krysiak R; Okopien B
Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):251-6. PubMed ID: 25123447
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia.
Krysiak R; Gilowski W; Szkrobka W; Okopien B
Cardiovasc Ther; 2015 Oct; 33(5):282-7. PubMed ID: 26146893
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Ethinyl Estradiol on Metformin Action on Prolactin Levels in Women with Hyperprolactinemia.
Krysiak R; Szkróbka W; Okopień B
Exp Clin Endocrinol Diabetes; 2021 Jan; 129(1):22-28. PubMed ID: 31234219
[TBL] [Abstract][Full Text] [Related]
8. Prolactin Response to Metformin in Cabergoline-Resistant Prolactinomas: A Pilot Study.
Portari LHC; Correa-Silva SR; Abucham J
Neuroendocrinology; 2022; 112(1):68-73. PubMed ID: 33477154
[TBL] [Abstract][Full Text] [Related]
9. Myo-Inositol Potentiates the Inhibitory Effect of Metformin on Prolactin Levels.
Krysiak R; Basiak M; Szkróbka W; Okopień B
Pharmacology; 2023; 108(3):238-244. PubMed ID: 36739860
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D status determines the impact of metformin on circulating prolactin levels in premenopausal women.
Krysiak R; Kowalcze K; Okopień B
J Clin Pharm Ther; 2021 Oct; 46(5):1349-1356. PubMed ID: 34076286
[TBL] [Abstract][Full Text] [Related]
11. Different Effects of Metformin on the Hypothalamic-Pituitary-Thyroid Axis in Bromocriptine- and Cabergoline-treated Patients with Hashimoto's Thyroiditis and Glucose Metabolism Abnormalities.
Krysiak R; Okrzesik J; Okopien B
Exp Clin Endocrinol Diabetes; 2015 Oct; 123(9):561-6. PubMed ID: 26372847
[TBL] [Abstract][Full Text] [Related]
12. Sex-Dependent Effect of Metformin on Serum Prolactin Levels In Hyperprolactinemic Patients With Type 2 Diabetes: A Pilot Study.
Krysiak R; Szkróbka W; Okopień B
Exp Clin Endocrinol Diabetes; 2018 Jun; 126(6):342-348. PubMed ID: 29169197
[TBL] [Abstract][Full Text] [Related]
13. The impact of oral hormonal contraception on metformin action on hypothalamic-pituitary-thyroid axis activity in women with diabetes and prediabetes: A pilot study.
Krysiak R; Kowalcze K; Wolnowska M; Okopień B
J Clin Pharm Ther; 2020 Oct; 45(5):937-945. PubMed ID: 31903641
[TBL] [Abstract][Full Text] [Related]
14. Different effects of fenofibrate on cardiometabolic risk factors in young women with and without hyperprolactinemia.
Krysiak R; Szkróbka W; Okopień B
Pharmacol Rep; 2019 Feb; 71(1):61-66. PubMed ID: 30469130
[TBL] [Abstract][Full Text] [Related]
15. Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults.
Gibson CD; Karmally W; McMahon DJ; Wardlaw SL; Korner J
Diabetes Obes Metab; 2012 Apr; 14(4):335-40. PubMed ID: 22074059
[TBL] [Abstract][Full Text] [Related]
16. The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidism.
Krysiak R; Gilowska M; Szkróbka W; Okopień B
Pharmacol Rep; 2016 Apr; 68(2):490-4. PubMed ID: 26922558
[TBL] [Abstract][Full Text] [Related]
17. Current treatment issues in female hyperprolactinaemia.
Crosignani PG
Eur J Obstet Gynecol Reprod Biol; 2006 Apr; 125(2):152-64. PubMed ID: 16288952
[TBL] [Abstract][Full Text] [Related]
18. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
Rains CP; Bryson HM; Fitton A
Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
[TBL] [Abstract][Full Text] [Related]
19. Prolactin levels in infertility and bromocriptine therapy in hyperprolactinaemia.
Prathibha D; Govardhani M; Krishna PT
J Indian Med Assoc; 1994 Dec; 92(12):397-9. PubMed ID: 7876578
[TBL] [Abstract][Full Text] [Related]
20. Sexual Functioning in Hyperprolactinemic Patients Treated With Cabergoline or Bromocriptine.
Krysiak R; Okopień B
Am J Ther; 2019; 26(4):e433-e440. PubMed ID: 29746287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
